A Study of LXI-15029 in Patients With Advanced Malignant Solid Tumors
Clinical trial NCT03125746 · UNKNOWN
Trial details
- NCT number
- NCT03125746
- Sponsor
- Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-12
- Primary completion
- 2021-10-28
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.